SCHEMBL4671748

SCHEMBL4671748

NC(=O)c1ccccc1OCC(=O)NC1CC2CCC(C1)N2Cc1ccc(Cl)cc1.O=C(COc1ccc2c(c1)OCO2)NC1CC2CCC(C1)N2Cc1ccc(Cl)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.51
NPC1 O15118 5/20 0.51
MCHR1 Q99705 3/20 0.46
KCNH2 Q12809 4/20 0.46
OPRK1 P41145 2/20 0.46
OPRM1 P35372 2/20 0.46
OPRD1 P41143 1/20 0.46
KMT2A Q03164 2/20 0.43
RECQL P46063 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CXCR6 O00574 1/20 0.42
MEN1 O00255 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
CYP3A4 P08684 2/20 0.42
ABCB11 O95342 1/20 0.42
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
ADRA2A P08913 1/20 0.42
CYP2D6 P10635 1/20 0.42
CHRM1 P11229 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4671746 1.00 RAB9A (0.51) RAB9ANPC1MCHR1KCNH2OPRK1
SCHEMBL3871393 0.90 MCHR1 (0.53) RAB9ANPC1MCHR1KCNH2OPRK1
SCHEMBL3871401 0.90 MCHR1 (0.53) RAB9ANPC1MCHR1KCNH2OPRK1
SCHEMBL3871017 0.88 KCNH2 (0.56) KCNH2OPRK1KMT2ACXCR6MEN1
SCHEMBL3871013 0.88 KCNH2 (0.56) KCNH2OPRK1KMT2ACXCR6MEN1
SCHEMBL3873444 0.81 NPC1 (0.53) RAB9ANPC1MCHR1KCNH2OPRK1
SCHEMBL3873441 0.81 NPC1 (0.53) RAB9ANPC1MCHR1KCNH2OPRK1
SCHEMBL3869587 0.78 ATF4 (0.66) OPRK1KMT2ACXCR6MEN1LMNA
SCHEMBL3869586 0.78 ATF4 (0.66) OPRK1KMT2ACXCR6MEN1LMNA
SCHEMBL3869675 0.77 ALDH1A1 (0.57) OPRK1SMN1; SMN2CXCR6LMNADRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1891064-A1 N-AMIDE DERIVATIVES OF 8-AZABICYCLO[3.2.1]OCT-3-YL AS CCR1 ANTAGONISTS Laboratorios Almirall, S.A. (ES) 2008-02-27 EP claimed
WO-2006133802-A1 N-AMIDE DERIVATIVES OF 8-AZABICYCLO[3.2.1]OCT-3-YL AS CCR1 ANTAGONISTS LABORATORIOS ALMIRALL, S.A. (ES) 2006-12-21 WO claimed
EP-1891064-A1 N-AMIDE DERIVATIVES OF 8-AZABICYCLO[3.2.1]OCT-3-YL AS CCR1 ANTAGONISTS Laboratorios Almirall, S.A. (ES) 2008-02-27 EP disclosed
WO-2006133802-A1 N-AMIDE DERIVATIVES OF 8-AZABICYCLO[3.2.1]OCT-3-YL AS CCR1 ANTAGONISTS LABORATORIOS ALMIRALL, S.A. (ES) 2006-12-21 WO disclosed